Abstract
Neuroimaging studies have provided a major contribution to our understanding of the mechanisms of the placebo effect in neurological and psychiatric disorders. Expectation of symptom improvement has long been believed to play a critical role in the placebo effect, and is associated with increased endogenous striatal dopamine release in Parkinson’s disease and increased endogenous opioid transmission in placebo analgesia. Evidence from positron emission tomography and functional magnetic resonance imaging studies suggests that expectations of symptom improvement are driven by frontal cortical areas, particularly the dorsolateral prefrontal, orbitofrontal, and anterior cingulate cortices. The ventral striatum is involved in the expectation of rewarding stimuli and, together with the prefrontal cortex, has also been shown to play an important role in the placebo-induced expectation of therapeutic benefit. Understanding the mechanisms of the placebo effect has important implications for treatment of several medical conditions, including depression, pain, and Parkinson’s disease.
Similar content being viewed by others
References
Lindvall O, Bjorklund A (1978) Anatomy of the dopaminergic neuron systems in the rat brain. Adv Biochem Psychopharmacol 19:1–23
Haber SN, Fudge JL (1997) The primate substantia nigra and VTA: integrative circuitry and function. Crit Rev Neurobiol 11(4):323–342
Joel D, Weiner I (2000) The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96(3):451–474
Haber SN (2003) The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 26(4):317–330
Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357–381
Stewart-Williams S, Podd J (2004) The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull 130(2):324–340
de Craen AJ, Tijssen JG, de Gans J, Kleijnen J (2000) Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 247(3):183–188
Brody H (1980) Placebos and the philosophy of medicine: clinical, conceptual, and ethical issues. Chicago: The University of Chicago Press
Kaptchuk TJ, Goldman P, Stone DA, Stason WB (2000) Do medical devices have enhanced placebo effects? J Clin Epidemiol 53(8):786–792
Shapiro AK, Shapiro E (1997) The placebo: is it much ado about nothing? In: Harrington A (ed) The placebo effect: an interdisciplinary exploration. Cambridge: Harvard University Press, pp 12–36
Moseley JB, O’Malley K, Petersen NJ, et al. (2002) A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 347(2):81–88
de la Fuente-Fernandez R, Stoessl AJ (2002) The biochemical bases for reward. Implications for the placebo effect. Eval Health Prof 25(4):387–398
Diamond SG, Markham CH, Treciokas LJ (1985) Double-blind trial of pergolide for Parkinson’s disease. Neurology 35(3):291–295
Goetz CG, Leurgans S, Raman R (2002) Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson’s disease. Mov Disord 17(2):283–288
Goetz CG, Leurgans S, Raman R, Stebbins GT (2000) Objective changes in motor function during placebo treatment in PD. Neurology 54(3):710–714
Shetty N, Friedman JH, Kieburtz K, Marshall FJ, Oakes D (1999) The placebo response in Parkinson’s disease. Parkinson Study Group. Clin Neuropharmacol 22(4):207–212
Freeman TB, Vawter DE, Leaverton PE, et al. (1999) Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson’s disease. N Engl J Med 341(13):988–992
Macklin R (1999) The ethical problems with sham surgery in clinical research. N Engl J Med 341(13):992–996
Weijer C (2002) I need a placebo like I need a hole in the head. J Law Med Ethics 30(1):69–72
London AJ, Kadane JB (2002) Placebos that harm: sham surgery controls in clinical trials. Stat Methods Med Res 11(5):413–427
Watts RL, Freeman TB, Hauser RA, et al. (2001) A double-blind, randomised, controlled, multicenter clinical trial of the safety and efficacy of stereotaxic intrastriatal implantation of fetal porcine ventral mesencephalic tissue (Neurocell™-PD) vs. imitation surgery in patients with Parkinson’s disease (PD). Parkinsonism Relat Disord 7:S87
Olanow CW, Goetz CG, Kordower JH, et al. (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Ann Neurol 54(3):403–414
Hauser RA, Freeman TB, Snow BJ, et al. (1999) Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 56(2):179–187
Freed CR, Greene PE, Breeze RE, et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N Engl J Med 344(10):710–719
McRae C, Cherin E, Yamazaki TG, et al. (2004) Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry 61(4):412–420
Fuente-Fernandez R, Schulzer M, Stoessl AJ (2002) The placebo effect in neurological disorders. Lancet Neurol 1(2):85–91
Mercado R, Constantoyannis C, Mandat T, et al. (2006) Expectation and the placebo effect in Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. Mov Disord 21(9):1457–1461
Pollo A, Torre E, Lopiano L, et al. (2002) Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. Neuroreport 13(11):1383–1386
Benedetti F, Pollo A, Lopiano L, et al. (2003) Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 23(10):4315–4323
Benedetti F, Colloca L, Lanotte M, et al. (2004) Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region. Brain Res Bull 63(3):203–211
Benedetti F, Colloca L, Torre E, et al. (2004) Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci 7(6):587–588
Dewey SL, Smith GS, Logan J, et al. (1993) Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc Natl Acad Sci U S A 90(24):11816–11820
Endres CJ, Kolachana BS, Saunders RC, et al. (1997) Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies. J Cereb Blood Flow Metab 17(9):932–942
Breier A, Su TP, Saunders R, et al. (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A 94(6):2569–2574
Volkow ND, Wang GJ, Fowler JS, et al. (1999) Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D2 receptors. J Pharmacol Exp Ther 291(1):409–415
Drevets WC, Gautier C, Price JC, et al. (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49(2):81–96
Volkow ND, Wang G, Fowler JS, et al. (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21(2):RC121
Leyton M, Boileau I, Benkelfat C, et al. (2002) Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology 27(6):1027–1035
Martinez D, Slifstein M, Broft A, et al. (2003) Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23(3):285–300
Oswald LM, Wong DF, McCaul M, et al. (2005) Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 30(4):821–832
Schlaepfer TE, Pearlson GD, Wong DF, Marenco S, Dannals RF (1997) PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry 154(9):1209–1213
Brody AL, Olmstead RE, London ED, et al. (2004) Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161(7):1211–1218
Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A (2004) The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride. Synapse 54(2):65–71
Volkow ND, Wang GJ, Telang F, et al. (2006) Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26(24):6583–6588
Adler CM, Elman I, Weisenfeld N, et al. (2000) Effects of acute metabolic stress on striatal dopamine release in healthy volunteers. Neuropsychopharmacology 22(5):545–550
Zald DH, Boileau I, El Dearedy W, et al. (2004) Dopamine transmission in the human striatum during monetary reward tasks. J Neurosci 24(17):4105–4112
Koepp MJ, Gunn RN, Lawrence AD, et al. (1998) Evidence for striatal dopamine release during a video game. Nature 393(6682):266–268
Piccini P, Pavese N, Brooks DJ (2003) Endogenous dopamine release after pharmacological challenges in Parkinson’s disease. Ann Neurol 53(5):647–653
de la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. (2001) Expectation and dopamine release: mechanism of the placebo effect in parkinson’s disease. Science 293(5532):1164–1166
Strafella AP, Ko JH, Monchi O (2006) Therapeutic application of transcranial magnetic stimulation in Parkinson’s disease: the contribution of expectation. Neuroimage 31(4):1666–1672
Kirsch I (1997) Specifying nonspecifics: psychological mechanisms of placebo effects. In: Harrington A (ed) The placebo effect: an interdisciplinary exploration. Cambridge: Harvard University Press, pp 166–186
de la Fuente-Fernandez R, Phillips AG, Zamburlini M, et al. (2002) Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res 136(2):359–363
Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev 28(3):309–369
Ikemoto S, Panksepp J (1999) The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Rev 31(1):6–41
Mogenson GJ, Jones DL, Yim CY (1980) From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14(2–3):69–97
Apicella P, Scarnati E, Ljungberg T, Schultz W (1992) Neuronal activity in monkey striatum related to the expectation of predictable environmental events. J Neurophysiol 68(3):945–960
Fiorillo CD, Tobler PN, Schultz W (2003) Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299(5614):1898–1902
Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction and reward. Science 275(5306):1593–1599
Schultz W (1998) Predictive reward signal of dopamine neurons. J Neurophysiol 80(1):1–27
Schultz W, Apicella P, Scarnati E, Ljungberg T (1992) Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci 12(12):4595–4610
Evans AH, Pavese N, Lawrence AD, et al. (2006) Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 59(5):852–858
Colloca L, Lopiano L, Lanotte M, Benedetti F (2004) Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol 3(11):679–684
Horvitz JC (2000) Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 96(4):651–656
Ljungberg T, Apicella P, Schultz W (1992) Responses of monkey dopamine neurons during learning of behavioral reactions. J Neurophysiol 67(1):145–163
Mirenowicz J, Schultz W (1994) Importance of unpredictability for reward responses in primate dopamine neurons. J Neurophysiol 72(2):1024–1027
Montague PR, Dayan P, Sejnowski TJ (1996) A framework for mesencephalic dopamine systems based on predictive Hebbian learning. J Neurosci 16(5):1936–1947
Montague PR, Hyman SE, Cohen JD (2004) Computational roles for dopamine in behavioural control. Nature 431(7010):760–767
Dreher JC, Kohn P, Berman KF (2006) Neural coding of distinct statistical properties of reward information in humans. Cereb Cortex 16(4):561–573
Phillips AG, Blaha CD, Fibiger HC (1989) Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses. Neurosci Biobehav Rev 13(2–3):99–104
Garris PA, Kilpatrick M, Bunin MA, et al. (1999) Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation. Nature 398(6722):67–69
Phillips PE, Stuber GD, Heien ML, Wightman RM, Carelli RM (2003) Subsecond dopamine release promotes cocaine seeking. Nature 422(6932):614–618
Breiter HC, Rosen BR (1999) Functional magnetic resonance imaging of brain reward circuitry in the human. Ann N Y Acad Sci 877:523–547
Delgado MR, Nystrom LE, Fissell C, Noll DC, Fiez JA (2000) Tracking the hemodynamic responses to reward and punishment in the striatum. J Neurophysiol 84(6):3072–3077
Elliott R, Friston KJ, Dolan RJ (2000) Dissociable neural responses in human reward systems. J Neurosci 20(16):6159–6165
Pagnoni G, Zink CF, Montague PR, Berns GS (2002) Activity in human ventral striatum locked to errors of reward prediction. Nat Neurosci 5(2):97–98
Knutson B, Adams CM, Fong GW, Hommer D (2001) Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 21(16):RC159
Beiter HC, Gollub RL, Weisskoff RM, et al. (1997) Acute effects of cocaine on human brain activity and emotion. Neuron 19(3):591–611
Volkow ND, Wang GJ, Ma Y, et al. (2006) Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects. Neuroimage 32(4):1782–1792
Knutson B, Westdorp A, Kaiser E, Hommer D (2000) FMRI visualization of brain activity during a monetary incentive delay task. Neuroimage 12(1):20–27
Breiter HC, Aharon I, Kahneman D, Dale A, Shizgal P (2001) Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron 30(2):619–639
Knutson B, Fong GW, Adams CM, Varner JL, Hommer D (2001) Dissociation of reward anticipation and outcome with event-related fMRI. Neuroreport 12(17):3683–3687
Berns GS, McClure SM, Pagnoni G, Montague PR (2001) Predictability modulates human brain response to reward. J Neurosci 21(8): 2793–2798
O’Doherty JP, Deichmann R, Critchley HD, Dolan RJ (2002) Neural responses during anticipation of a primary taste reward. Neuron 33(5):815–826
Risinger RC, Salmeron BJ, Ross TJ, et al. (2005) Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage 26(4):1097–1108
Small DM, Jones-Gotman M, Dagher A (2003) Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 19(4):1709–1715
Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A (2004) The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride. Synapse 54(2):65–71
Martinez D, Gil R, Slifstein M, et al. (2005) Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 58(10):779–786
Kaasinen V, Aalto S, Nagren K, Rinne JO (2004) Expectation of caffeine induces dopaminergic responses in humans. Eur J Neurosci 19(8):2352–2356
Levine JD, Gordon NC, Fields HL (1978) The mechanism of placebo analgesia. Lancet ii:654
Gracely RH, Dubner R, Wolskee PJ, Deeter WR (1983) Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature 23(306):264–265
Levine JD, Gordon NC (1984) Influence of the method of drug administration on analgesic response. Nature 312(5996):755–756
Benedetti F (1996) The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 64(3):535–543
Amanzio M, Benedetti F (1999) Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 19(1):484–494
Zubieta JK, Smith YR, Bueller JA, et al. (2001) Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293(5528):311–315
Zubieta JK, Bueller JA, Jackson LR, et al. (2005) Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 25(34):7754–7762
Wager TD, Rilling JK, Smith EE, et al. (2004) Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303(5661):1162–1167
Voudouris NJ, Peck CL, Coleman G (1989) Conditioned response models of placebo phenomena: further support. Pain 38(1):109–116
Montgomery GH, Kirsch I (1997) Classical conditioning and the placebo effect. Pain 72(1–2):107–113
Price DD, Milling LS, Kirsch I, et al. (1999) An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 83(2):147–156
Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK (2005) Neurobiological mechanisms of the placebo effect. J Neurosci 25(45):10390–10402
Petrovic P, Kalso E, Petersson KM, Ingvar M (2002) Placebo and opioid analgesia—imaging a shared neuronal network. Science 295(5560):1737–1740
Kong J, Gollub RL, Rosman IS, et al. (2006) Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci 26(2):381–388
Benedetti F, Arduino C, Amanzio M (1999) Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci 19(9):3639–3648
Colloca L, Benedetti F (2005) Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci 6(7):545–552
Walsh BT, Seidman SN, Sysko R, Gould M (2002) Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287(14):1840–1847
Mayberg HS, Silva JA, Brannan SK, et al.(2002) The functional neuroanatomy of the placebo effect. Am J Psychiatry 159(5):728–737
Kirsch I, Sapierstein G (1998) Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medications. Prev Treat 1(6):2a
Mayberg HS, Brannan SK, Tekell JL, et al. (2000) Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 48(8):830–843
Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M (2002) Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 159(1):122–129
Hunter AM, Leuchter AF, Morgan ML, Cook IA (2006) Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry 163(8):1426–1432
Lidstone SC, de la Fuente-Fernandez R, Stoessl AJ (2005) The placebo response as a reward mechanism. Semin Pain Med 4(1):37–42
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s11307-007-0098-z.
Rights and permissions
About this article
Cite this article
Lidstone, S.C.C., Stoessl, A.J. Understanding the Placebo Effect: Contributions from Neuroimaging. Mol Imaging Biol 9, 176–185 (2007). https://doi.org/10.1007/s11307-007-0086-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-007-0086-3